info@unitedpharma.us  | +1 (347) 486-4833

United Conference of Pharmacovigilance

Theme : The Novel and Contemporary Research in Pharmacovigilance

Webinar on Pharmacovigilance | April 6, 2021

Conference Brochure
Abstract Submission
Registration
Scientific Program

About The Conference

On behalf of United Conferences, we are overwhelmed to welcome all the interested participants to attend “United Conference of Pharmacovigilance” Webinar Event on April 6th, 2021. This conference boats of a huge variety of Keynote presentations, plenary talks, Poster presentations and Career development programs.

United Conference on Pharmacovigilance aims to bring together a significant number of leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacovigilance  It is a foremost integrative platform for researchers, educators and practitioners alike to present and explore the latest innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacovigilance 

Who Can Attend

  • Deans, Directors, CEO of an Organization
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Biosimilar and Biologic Industries
  • PhD Scholars
  • Professors, Associate professors, Assistant Professors
  • Drug Development Discovery Companies
  • Association, Association Presidents and Professionals
  • Formulation and Pharma Manufacturing Companies
  • Business Entrepreneurs
  • Medical Software Developing Companies
  • Manufacturing Medical Devices Companies
  • Intellectual Property Attorneys
  • Noble laureates in Health Care and Medicine
  • Pharmacists
  • Bio-instruments and Bio-informatics Professionals
  • Research Institutes and members
  • Pharmacy Institutes

Why Choose Us

  • Global & Local Expertise
  • Prospective Attendees
  • Larger worldview of the profession
  • We’re passionate about what we do
  • We focus on your career growth
  • Transparency in Communication
  • Open gateway towards INNOVATION
  • Strong sense of identification
  • Quality without compromise
  • Quality without compromise
  • Highly organised and structured scientific programs

Key Takeaways

  • CME / CNE / CPE / CDE Credits
  • Professional Worldwide
  • International Recognition of Researchers
  • Knowledge into Asset
  • Cognizance of leading Cutting – Edge technologies
  • Publication of Abstracts in preeminent supported journals
  • New Accomplishments with Edu – tech ideas
  • Exposure to the upcoming business trends
  • Free access to our forthcoming International events
  • Certificate of presentation with International signatories

Scientific Sessions

  • Adverse Drug Reactions
  • Analysis of Data Quality And Management
  • Biomarkers in Drug Design
  • Causality Assessment
  • Clinical Research and Statistics
  • Clinical Trial Protocols
  • Clinical Trials in Oncology
  • Clinical Trials on Various Disorders
  • Diversity in Industrial Clinical Trials And Clinical Research
  • Drug Design and Safety
  • Drug Designing and Development
  • Ethics in Clinical Trials
  • Future in Clinical Trials
  • Health Technology Assessment
  • Identifying the Ethical Challenges
  • Inhuman Clinical Trials
  • Interventional Clinical Trials
  • Medical Device Research
  • Orphan Drugs
  • Patient Identification
  • Pharmacovigilance
  • Pharmacovigilance Practice
  • Pre-Clinical and Clinical Trials
  • PV Consulting and Business Opportunity
  • Regulatory Affairs
  • Veterinary Clinical Trials

Keynotes

Graeme Ladds

CEO PharSafer Associates Ltd - Global Leaders in Drug Safety, United Kingdom

Nashwa Nashaat

CEO & Co-Founder Nexus eHealth Formal regional Medical Director for J&J and Eli Lilly Novartis: Pharmacovigilance Lead

Liana Kasyan

Founder/CEO and Principal PV Consultant at ETL Pharmacovigilance Center Ltd. Armenia

Julia Appelskog

EU QPPV, Head of QPPVs & Safety Consulting. Pharmacovigilance Director, Sweden

Penelope Przekop

Chief Compliance Officer at Engrail Therapeutics | CEO at PDC Pharma Strategy, Greater Philadelphia

Speakers

Conferences Agenda

Day-1

  • 08:00-09:30: Session: Pharmacovigilance & Adverse Drug Reactions
  • 09:30-10:30: Session: Analysis of Data Quality and Management
  • 10:30-11:00: Session: Biomarkers in Drug Design
  • 11:00-12:00: Session: Clinical Research and Statistics
  • 12:00-12:30: Session: Clinical Trial Protocols
  • 13:00-14:00: Session: Clinical Trials in Oncology
  • 14:00-15:00: Session: Clinical Trials on Various Disorders
  • 15:00-16:00: Session: Drug Design and Safety

Day-2

  • 08:00-09:30: Session: Drug Designing and Development
  • 09:30-10:30: Session: Ethics in Clinical Trials
  • 10:30-11:00: Session: Future in Clinical Trials
  • 11:00-12:00: Session: Health Technology Assessment
  • 12:00-12:30: Session: Inhuman Clinical Trials
  • 13:00-14:00: Session: Interventional Clinical Trials
  • 14:00-15:00: Session: Pharmacovigilance Practice
  • 15:00-16:00: Session: Pre-Clinical and Clinical Trials

Webinar Registration Charges

  • Speaker Registration 0 USD
  • Delegate Registration 79 USD
  • Student Delegate 50 USD
  • Virtual Exhibitor 599 USD

United Pharma Technologies Collaborations and Associations

Biography: Graeme Ladds has worked in Global Pharmacovigilance and Medical Affairs for the last 30 years working with many top ten Pharma in senior positions. He has worked in all areas of Pharmacovigilance and has designed and improved many IT solutions to aid both Medical Affairs and Pharmacovigilance. Graeme is also an experienced GCP/PV auditor having audited many Companies globally as well as helping Companies in Regulatory Inspections. He now works in his CRO - PharSafer Associates Ltd
Nashwa Nashaat
CEO & Co-Founder Nexus eHealth Formal regional Medical Director for J&J and Eli Lilly Novartis: Pharmacovigilance Lead
Biography: She has dedicated her career to improving the patients’ care and healthcare services. Inspired by the advancement in technology and her personal mission to serve patients, she has co-founded a company where the unmet patient’s needs drive the innovation for personalized technology-based solutions. In her role as a Chief Executive Officer and Co-founder for Nexus eHealth, she is committed to being a catalyst in the adoption of precision medicine through the Technology Enabled Connected Care solutions and building the healthcare technology capabilities, especially in the Middle East and Africa.
Prior to founding Nexus eHealth, being a physician; with PhD in Pediatric Oncology/Hematology, she devoted her passion to improve cancer patients’ lives and affordability of medicine by working with different global medical societies, NGOs and policy makers for more than 18 years. She has also worked for top multinational pharmaceutical, diagnostics and medical devices companies (Novartis, Eli Lilly and Johnson & Johnson) during the last 11 years where she took several global executive leadership roles in R&D, GxP auditing, medical affairs, patients advocacy and support programs, governmental affairs, business development, market access, healthcare policies and digital transformation strategies.

She was honored with 25 global awards for innovation, excellence and patient centricity. She authored more than 20 scientific publications. She serves as technical advisor and organizational leadership coach qualified by Glasgow university. She has been volunteering in different community services in Africa and a member in the Global Camper of Commerce and Industry (GCCI) that support the spirit of entrepreneurship. She is an Egyptian woman who constantly advocates the promotion of equality, diversity and inclusion & woman empowerment across the corporate world and the society as a whole.
Liana Kasyan
Founder/CEO and Principal PV Consultant at ETL Pharmacovigilance Center Ltd. Armenia
Biography: Founder/CEO and Principal PV Consultant at the ETL Pharmacovigilance Center Ltd., - Pharmacovigilance Instructor at the Open Education Office of the American University of Armenia, - Member of International Society of Pharmacovigilance (ISoP), - International Editorial Board Member for the Journal of Pharmacovigilance and Drug Research (JPADR), - Reviewer of Master Тheses at the Faculty of Public Health of Yerevan State Medical University, - Board Member of Armenian Association of Specialists in Evidence-Based Medicine (AASEBM), - Co-founder of “Do not Harm’’ Health NGO.

Submit Manuscript

Manuscript Details

Author Details